In the on-going drive towards VOC compliant coatings, DSM NeoResins+ has successfully developed a new, high performance, polyurethane dispersion for parquet flooring applications.
NeoRez® R-9029 is a water based fatty acid modified, aliphatic polyurethane dispersion specially developed for fast curing 1K floor finishes.
This NMP free, but pre-coalesced, new development provides excellent black heel mark and scuff resistance within 3 days drying, without the need for additional driers. NeoRez® R-9029 delivers the same warm amber look of traditional solvent based coatings while meeting the defined 2010 European VOC directives.

About DSM NeoResins+
DSM NeoResins+ is a leading, committed, global supplier of innovative specialty resins, specialized in the development and manufacturing of resins that is focused on fulfilling the needs of the coatings and graphic arts industries. DSM NeoResins’ existing brand names Haloflex®, Halwedrol®, NeoCryl®, NeoRez® , NeoPac®, NeoRad®, Uracron®, Uradil® and Uralac® are well-known throughout the industries world-wide.
DSM NeoResins+ has 1,200 employees and operates seven manufacturing sites: in Frankfort and Wilmington (US), Shunde (China), Hoek van Holland and Waalwijk (Netherlands), Meppen (Germany) and Parets (Spain). Being focused on customer needs, it has five Application and Research & Technology Centers: in Wilmington (US), Shanghai and Shunde (China), Parets (Spain), Waalwijk and Zwolle (Netherlands), all supported by three Customer Service Centers: in Wilmington (US), Shunde (China) and Waalwijk (Netherlands). DSM NeoResins+ is headquartered in Waalwijk (Netherlands). More information on DSM NeoResins+ can be found at www.dsmneoresins.com.

About DSM
DSM creates innovative products and services in Life Sciences and Materials Sciences, contributing to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and enjoyable way of living. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics & electronics, life protection and housing. The company strategy, Vision 2010 – Building on Strengths, focuses on accelerating profitable and innovative growth of the company’s specialties portfolio. The key drivers of this strategy are market-driven growth and innovation, an increased presence in emerging economies and operational excellence. DSM has annual sales of almost EUR 9 billion and employs some 22,000 people worldwide. The company is headquartered in the Netherlands, with locations in Europe, Asia, the Americas, Africa and Australia. More information on DSM can be found at www.dsm.com .